We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sat Sol World | SAT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 8.60 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.60 | 8.60 |
| Top Posts |
|---|
Posted at 14/5/2018 08:18 by quepassa Sunday 13th. May. -Mail on Sunday" MIDAS SHARE TIPS UPDATE:Investors are beaming as Sat Sol Worldwide's shares double in price" "Midas verdict: SSW has grown rapidly ..........But the best is yet to come.Existing investors should hold whilst new investors could still see value at today's price" See full article hXXp://www.thisismon Very encouraging and upbeat article. ALL IMO. DYOR. QP |
Posted at 26/4/2018 16:46 by hausofmaus I think a share price of (say) 127.5p gives us more credibility than 8.5p, and potentially gets a new tranche of investors onboard, who wouldn't be interested in a 'penny share' - imho, obviously! |
Posted at 26/4/2018 09:27 by quepassa All good points. Fully agree.Massive support and comfort at the quality of investors putting money into the Placing. Also very encouraging and a highly positive sign that their bankers, HSBC, are prepared to increase significantly SatSol's banking facilities. HSBC would not do that lightly. Such support from equity investors and bankers is a big vote of confidence in SatSol. ALL IMO. DYOR. QP |
Posted at 05/4/2018 10:22 by quepassa Investors Chronicle Edition 29th. March.Page 14. Article headed "Satellite Solution's in the ascent" "....suggesting a further 30% share price upside. Buy". ALL IMO. DYOR. QP |
Posted at 25/3/2018 21:39 by tightfist SAT results in the morning(!); I expect really good progress IMO. Is anyone else going to the investors results presentation in the afternoon? tightfist |
Posted at 09/2/2018 11:47 by quepassa Detailed article by Simon Thompson on p15 of today's Investors Chronicle.Worth reading full article which ends on the following words: "... a target enterprise value to cash profit multiple of 9.5 times for the 2018-19 financial year is reasonable, suggesting a further 30% share price upside. Buy." Good analysis. Good article. Good news. ALL IMO. DYOR. QP |
Posted at 31/8/2017 07:48 by qs99 Yup, with broker TP around 11-12p from what I recall posters saying (can't see that sort of info now on the new rubbish Barclays Smart Investor a/c) they should IMO start trending towards those prices....DYOR and gla |
Posted at 11/7/2017 13:16 by mrnumpty Am I the only shareholder who , on going to the " Investor Relations " section of the website of SSW , and on pressing on " RNS and Investor News " , and then pressing on today's RNS , is unable to obtain any further information ? I am not aware of any problem withy either my computer or my internet connection . I had the same problem two or three months ago and sent an e-mail to the company which manages their investor relations , but don't seem to have ever received a reply . |
Posted at 10/7/2017 13:26 by mrnumpty Thanks to Gonedown for your reply . It's always regarded as unfair on paying subscribers if one quotes an entire article concerning a share , but the essence of the latest comment by Simon Thompson in the Investors Chronicle ( " Four small-Cap buys " , 7th July - 13th July ) is " Buy " at 7.25p , and he writes that " I feel my target price of 10.5p is not unreasonable and I rate the shares a buy ahead of the half-yearresults ' . Good luck and , as ever , do your own research . Mr. N. |
Posted at 21/3/2017 14:34 by tjbird This is where Seargeant has goneDERR Former Dominos boss Stephen Hemsley and serial investor Nigel Wray are backing a new venture in medical technology that will list on the London stock market next week after raising £2.3m from investors. The company, Derriston Capital, will float as a cash shell with the aim of making its first acquisition in the med-tech space three to six months after listing. Mr Wray, known as the Buffett of Britain, and Mr Hemsley, who is chief executive of Unitedhealth Group, each have an 8pc stake in the business, having invested £200,000 apiece. The new business is also backed by property investor Warren Todd, through his vehicle Courtney Investments, and Harry Hyman, founder of Primary Health Properties, a real estate investment trust focused on healthcare. Other big-name investors include Hargreave Hale, which as a 10pc slice in Derriston. Derriston’s finance director, Rodger Sargent, said Derriston’s first purchase would be a company, rather than a product, to give it instant scale, staff, infrastructure and a distribution network in which it can pump other products into. The strategy is to find medical devices that are already on the market, but which are under-invested and unloved by their parent companies. Derriston will acquire them into the cash shell through a reverse-takeover, outsource areas such as manufacturing, and ramp up sales to drive volume growth and bring costs down. “These products are basically non-core to giant med-tech companies,” explained Mr Sargent. “If you have a product with X turnover, and others with 500 times X, you won’t focus on the smaller ones. But we can take those, give them some love and attention and greatly increase the distribution and sales.” He said there was a growing market in the med-tech space for devices which are perhaps not the very best, but acceptable, lower-cost solutions for health authorities around the world which are coming under increasing strain from burgeoning and ageing populations. “We have had a decent look around and nothing is definite yet but we have a wish list of companies we are interested in,” said Mr Sargent. “Where we think we can really generate decent returns is getting into a particular genre or niche, be it by the technology type or the geographic region. The key will be forming relationships with distributors or clinics and sell a number of different products into the same distribution network. That is where operational gearing will come from.” After the first acquisition, Derriston might consider moving to an Aim-listing, which would allow it to raise money through the tax-efficient Enterprise Investment Scheme as it looks to expand its portfolio and tap investors for more cash. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
